[HTML][HTML] Patient preferences for biologicals in psoriasis: top priority of safety for cardiovascular patients
ML Schaarschmidt, C Kromer, R Herr, A Schmieder… - PloS one, 2015 - journals.plos.org
Patients with psoriasis are often affected by comorbidities, which largely influence treatment
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients.
ML Schaarschmidt, C Kromer, R Herr, A Schmieder… - Plos one, 2015 - europepmc.org
Patients with psoriasis are often affected by comorbidities, which largely influence treatment
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
[HTML][HTML] Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients
ML Schaarschmidt, C Kromer, R Herr, A Schmieder… - PLoS ONE, 2015 - ncbi.nlm.nih.gov
Patients with psoriasis are often affected by comorbidities, which largely influence treatment
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients
ML Schaarschmidt, C Kromer, R Herr, A Schmieder… - PLoS ONE, 2015 - go.gale.com
Patients with psoriasis are often affected by comorbidities, which largely influence treatment
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients.
ML Schaarschmidt, C Kromer, R Herr… - PLoS …, 2015 - search.ebscohost.com
Patients with psoriasis are often affected by comorbidities, which largely influence treatment
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
Patient preferences for biologicals in psoriasis: Top priority of safety for cardiovascular patients
ML Schaarschmidt, C Kromer, R Herr… - PloS …, 2015 - vivantes.elsevierpure.com
Patients with psoriasis are often affected by comorbidities, which largely influence treatment
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients
ML Schaarschmidt, C Kromer, R Herr… - PloS …, 2015 - pubmed.ncbi.nlm.nih.gov
Patients with psoriasis are often affected by comorbidities, which largely influence treatment
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
[PDF][PDF] Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients
ML Schaarschmidt, C Kromer, R Herr… - PLoS …, 2015 - pdfs.semanticscholar.org
Patients with psoriasis are often affected by comorbidities, which largely influence treatment
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
[引用][C] Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients
ML Schaarschmidt, C Kromer, R Herr… - PLoS …, 2015 - ui.adsabs.harvard.edu
Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular
Patients - NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS Patient …
Patients - NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS Patient …
Patient preferences for biologicals in psoriasis: Top priority of safety for cardiovascular patients
ML Schaarschmidt, C Kromer, R Herr… - PloS …, 2015 - vivantes.elsevierpure.com
Patients with psoriasis are often affected by comorbidities, which largely influence treatment
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …
decisions. Here we performed conjoint analysis to assess the impact of comorbidities on …